Yesterday, feeling snarky, I asked a rhetorical question: “What has United done for anyone lately?” The point, in the context of yet another set of record profits for UnitedHealth Group,

/ So UnitedHealth Group made about $5.5 billion in pure profit last quarter, with revenues nearing $100 billion. A huge chunk of that came from its Optum unit. The company’s

Programming Note: Cost Curve is probably off tomorrow, almost certainly off Friday, and definity off Monday. I’ll catch everyone up next week. J.P. Morgan put, arguably, the two hottest companies

The thing about J.P. Morgan is that you can draw overbroad conclusions after just 24 hours. The deals have been announced. Bellwether companies have provided a baseline. Attendees are not

A reminder: I’ll be carting my “Pitching Pricing” trading cards around #JPM24 today. If you want a pack, let me know your whereabouts. It’s a short one today, because I’ll

Hoo boy … is there ever a lot on my mind. Let’s get going. Late-breaking news: the FDA has green-lit Florida’s plan to import medicines from other countries.  I’m on

First off, there aren’t capital letters big enough to express the CONGRATS I’d like to pass along to Adam Fein, whose Drug Channels Institute has been acquired by HMP Global.

I have a quick rant below about the state of coverage of drug price increases, but I don’t want that to distract you from the drug-price story you should be

My goodness. 2024 already. For a lot of us, that means a scramble to get situated before the J.P. Morgan Healthcare conference begins this weekend. If you’re headed to SF,

We have our final two: it’ll be the CMS list of “selected drugs” under the IRA against the approval of Leqembi in the finals of Cost Curve Fight Club. You